Changes

no edit summary
Line 332: Line 332:  
|
 
|
 
|-
 
|-
|Precursor Lymphoid Neoplasms ||'''''Overview'''''|| ||Yassmine Akkari (YA)
+
|Precursor Lymphoid Neoplasms||'''''Overview'''''|| ||Yassmine Akkari (YA)
 
|
 
|
 
|
 
|
Line 396: Line 396:  
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|Mature B-Cell Neoplasms||'''''Overview'''''|| ||Snehal Patel (SP)
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|       Monoclonal B-cell  Lymphocytosis||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|B-cell Prolymphocytic Leukemia||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|Splenic Marginal Zone Lymphoma||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|Hairy Cell Leukemia||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|Splenic B-cell Lymphoma/Leukemia, Unclassifiable||'''''Overview'''''|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|    Hairy Cell Leukemia  Variant||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|Lymphoplasmacytic Lymphoma||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|   Waldenstrom  Macroglobulinemia||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|Heavy Chain Diseases||'''''Overview'''''|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|    Mu Heavy Chain  Disease||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|   Gamma Heavy Chain  Disease||Disease|| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|Example||Example|| ||Example
+
|    Alpha Heavy Chain  Disease||Disease|| ||SP
 
|
 
|
 
|
 
|